{"commentary":{"count":18,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":11,"youtube":4,"podcast":3},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT03186898\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"NCT03186898","nct_id":"NCT03186898","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct03186898. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":null,"arms":[{"description":"Patients undergo proton therapy over 15-24 days for 5 or 15 fractions. Patients undergo CT scan, MRI and blood sample collection throughout the study.","label":"Arm I (proton therapy)","type":"EXPERIMENTAL"},{"description":"Patients undergo photon therapy over 15-24 days for 5 or 15 fractions. Patients undergo CT scan, MRI and blood sample collection throughout the study.","label":"Arm II (photon therapy)","type":"EXPERIMENTAL"}],"collaborators":["National Cancer Institute (NCI)"],"completion_date":{"date":"2027-02-04","type":"ESTIMATED"},"conditions":["Recurrent Hepatocellular Carcinoma","Stage III Hepatocellular Carcinoma AJCC v7","Unresectable Hepatocellular Carcinoma"],"enrollment":{"count":115,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Biospecimen Collection","type":"PROCEDURE"},{"name":"Computed Tomography","type":"PROCEDURE"},{"name":"Laboratory Biomarker Analysis","type":"OTHER"},{"name":"Magnetic Resonance Imaging","type":"PROCEDURE"},{"name":"Quality-of-Life Assessment","type":"OTHER"},{"name":"Radiation Therapy","type":"RADIATION"},{"name":"Radiation Therapy","type":"RADIATION"}],"last_update":"2026-07-02","lead_sponsor":"NRG Oncology","official_title":"A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2026-01-20","type":"ACTUAL"},"primary_outcomes":[{"measure":"Overall survival (OS)","timeFrame":"From the date of randomization to the date of death due to any cause assessed up to 48 months after accrual closure"},{"measure":"Treatment effect","timeFrame":"Up to 48 months after accrual closure"}],"references":[{"citation":"Duda DG. Targeting Tumor Microenvironment in Liver Cancers: Rationale, Current Progress, and Future Perspective. Keio J Med. 2022;71(3):71. doi: 10.2302/kjm.71-004-ABST.","pmid":"36155490","type":"DERIVED"}],"start_date":{"date":"2018-01-26","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer","url":"https://clinicaltrials.gov/study/NCT03186898"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct03186898"}